|
28 Aug 2025 |
CCL Products
|
Consensus Share Price Target
|
853.80 |
923.70 |
- |
8.19 |
buy
|
|
|
|
|
08 Aug 2025
|
CCL Products
|
Keynote Capitals Ltd
|
853.80
|
1203.00
|
864.35
(-1.22%)
|
40.90 |
Buy
|
|
|
Quarterly Update Q1FY26
|
|
07 Aug 2025
|
CCL Products
|
IDBI Capital
|
853.80
|
849.00
|
862.65
(-1.03%)
|
Target met |
Hold
|
|
|
CCL Products Q1FY26 profitability was below our expectations. Sales grew 37% YoY to Rs10.7bn, driven by 9-10% YoY volume growth and 27-28% YoY increase in realization due to improved coffee blends. Gross margin contracted by 543bps YoY to 32.6%, driven by higher input cost. Consequently, EBITDA margin contracted by 178bps YoY to 15.1%. EBITDA grew 22% YoY to Rs1.6bn, driven by a favorable product mix in B2B and growth in the B2C category. PAT increased by 1% YoY to Rs724mn. CCL maintained its volume and EBITDA growth guidance of 10-20% and 15-20%, respectively. Management expects some price...
|
|
07 Aug 2025
|
CCL Products
|
Axis Direct
|
853.80
|
970.00
|
862.65
(-1.03%)
|
13.61 |
Buy
|
|
|
With a 12% upside from the CMP, we maintain our BUY rating on the stock.
|
|
07 May 2025
|
CCL Products
|
Keynote Capitals Ltd
|
853.80
|
1126.00
|
772.60
(10.51%)
|
31.88 |
Buy
|
|
|
Quarterly Update Q4FY25
|
|
07 May 2025
|
CCL Products
|
Axis Direct
|
853.80
|
800.00
|
772.60
(10.51%)
|
Target met |
Buy
|
|
|
With a 15% upside from the CMP, we maintain our BUY rating on the stock
|
|
06 May 2025
|
CCL Products
|
IDBI Capital
|
853.80
|
738.00
|
772.60
(10.51%)
|
Target met |
Hold
|
|
|
|
|
07 Feb 2025
|
CCL Products
|
IDBI Capital
|
853.80
|
698.00
|
654.35
(30.48%)
|
Target met |
Hold
|
|
|
|
|
07 Feb 2025
|
CCL Products
|
Keynote Capitals Ltd
|
853.80
|
1146.00
|
654.35
(30.48%)
|
34.22 |
Buy
|
|
|
Quarterly Update Q3FY25
|
|
07 Feb 2025
|
CCL Products
|
Axis Direct
|
853.80
|
730.00
|
654.35
(30.48%)
|
Target met |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our BUY rating on the stock.
|
|
28 Jan 2025
|
CCL Products
|
CD Equisearch
|
853.80
|
681.00
|
599.45
(42.43%)
|
Target met |
Accumulate
|
|
|
|
|
11 Nov 2024
|
CCL Products
|
Keynote Capitals Ltd
|
853.80
|
1222.00
|
713.05
(19.74%)
|
43.12 |
Buy
|
|
|
Quarterly Update Q2FY25
|
|
11 Nov 2024
|
CCL Products
|
BP Wealth
|
853.80
|
|
713.05
(19.74%)
|
|
Results Update
|
|
|
|
|
07 Nov 2024
|
CCL Products
|
IDBI Capital
|
853.80
|
734.00
|
691.70
(23.44%)
|
Target met |
Hold
|
|
|
|
|
07 Nov 2024
|
CCL Products
|
Axis Direct
|
853.80
|
820.00
|
701.40
(21.73%)
|
Target met |
Buy
|
|
|
With a 14% upside from the CMP, we maintain our BUY rating on the stock.
|
|
09 Sep 2024
|
CCL Products
|
Keynote Capitals Ltd
|
853.80
|
1221.00
|
747.05
(14.29%)
|
43.01 |
Buy
|
|
|
Initiating Coverage Report
|
|
09 Aug 2024
|
CCL Products
|
Axis Direct
|
853.80
|
760.00
|
659.85
(29.39%)
|
Target met |
Buy
|
|
|
With a 15% upside from the CMP, we maintain our BUY rating on the stock.
|
|
14 May 2024
|
CCL Products
|
Axis Direct
|
853.80
|
670.00
|
563.40
(51.54%)
|
Target met |
Buy
|
|
|
With a 17% upside from the CMP, we maintain our BUY rating on the stock.
|
|
14 May 2024
|
CCL Products
|
IDBI Capital
|
853.80
|
582.00
|
563.40
(51.54%)
|
Target met |
Hold
|
|
|
|
|
30 Mar 2024
|
CCL Products
|
CD Equisearch
|
853.80
|
645.00
|
586.30
(45.63%)
|
Target met |
Hold
|
|
|
|
|
07 Feb 2024
|
CCL Products
|
Axis Direct
|
853.80
|
720.00
|
667.35
(27.94%)
|
Target met |
Buy
|
|
|
With a 12% upside from the CMP, we maintain our BUY rating on the stock.
|